Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2019
RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting TherapeuticsLouise Usher, Pantazis I Theotokis, Sterghios A Moschos
Molecular Therapy. Nucleic Acids|December 17, 2017
Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAsPantazis I Theotokis, Louise Usher, Christopher K Kortschak, et al.
Hellenic Journal of Nuclear Medicine|December 6, 2019
Predicting oligonucleotide therapeutic efficacy at the population levelPantazis I Theotokis, L Usher, C K Kortschak, et al.
European Heart Journal|July 11, 2023
Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathyMona Allouba, Roddy Walsh, Alaa Afify, et al.
European Journal of Heart Failure|September 13, 2023
Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery diseaseRichard E Jones, Daniel J Hammersley, Sean Zheng, et al.
NPJ Genomic Medicine|October 28, 2020
The Egyptian Collaborative Cardiac Genomics (ECCO-GEN) Project: defining a healthy volunteer cohortYasmine Aguib, Mona Allouba, Alaa Afify, et al.
Circulation|January 28, 2020
Reevaluating the Genetic Contribution of Monogenic Dilated CardiomyopathyFrancesco Mazzarotto, Upasana Tayal, Rachel J Buchan, et al.
Journal of the American College of Cardiology|September 10, 2021
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic CardiomyopathyAntonio de Marvao, Kathryn A McGurk, Sean L Zheng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 13, 2020
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditionsXiaolei Zhang, Roddy Walsh, Nicola Whiffin, et al.
Pageof 2